20-62465895-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_080473.5(GATA5):c.852G>A(p.Lys284Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.489 in 1,594,492 control chromosomes in the GnomAD database, including 193,228 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.53 ( 22401 hom., cov: 34)
Exomes 𝑓: 0.48 ( 170827 hom. )
Consequence
GATA5
NM_080473.5 synonymous
NM_080473.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0710
Genes affected
GATA5 (HGNC:15802): (GATA binding protein 5) The protein encoded by this gene is a transcription factor that contains two GATA-type zinc fingers. The encoded protein is known to bind to hepatocyte nuclear factor-1alpha (HNF-1alpha), and this interaction is essential for cooperative activation of the intestinal lactase-phlorizin hydrolase promoter. In other organisms, similar proteins may be involved in the establishment of cardiac smooth muscle cell diversity. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 20-62465895-C-T is Benign according to our data. Variant chr20-62465895-C-T is described in ClinVar as [Benign]. Clinvar id is 1174638.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-62465895-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.071 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.666 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GATA5 | NM_080473.5 | c.852G>A | p.Lys284Lys | synonymous_variant | 5/7 | ENST00000252997.3 | NP_536721.1 | |
GATA5 | XM_006723699.3 | c.852G>A | p.Lys284Lys | synonymous_variant | 5/7 | XP_006723762.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GATA5 | ENST00000252997.3 | c.852G>A | p.Lys284Lys | synonymous_variant | 5/7 | 1 | NM_080473.5 | ENSP00000252997.2 |
Frequencies
GnomAD3 genomes AF: 0.533 AC: 81069AN: 152030Hom.: 22362 Cov.: 34
GnomAD3 genomes
AF:
AC:
81069
AN:
152030
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.474 AC: 103051AN: 217526Hom.: 24674 AF XY: 0.469 AC XY: 54954AN XY: 117282
GnomAD3 exomes
AF:
AC:
103051
AN:
217526
Hom.:
AF XY:
AC XY:
54954
AN XY:
117282
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.485 AC: 699016AN: 1442344Hom.: 170827 Cov.: 44 AF XY: 0.482 AC XY: 344976AN XY: 715542
GnomAD4 exome
AF:
AC:
699016
AN:
1442344
Hom.:
Cov.:
44
AF XY:
AC XY:
344976
AN XY:
715542
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.533 AC: 81162AN: 152148Hom.: 22401 Cov.: 34 AF XY: 0.530 AC XY: 39453AN XY: 74370
GnomAD4 genome
AF:
AC:
81162
AN:
152148
Hom.:
Cov.:
34
AF XY:
AC XY:
39453
AN XY:
74370
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1707
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 04, 2018 | - - |
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Congenital heart defects, multiple types, 5 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at